for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-ARCA Biopharma Announces AB201 Development Program For Treatment Of Covid-19 Associated Coagulopathy

May 28 (Reuters) - ARCA Biopharma Inc:

* ARCA BIOPHARMA ANNOUNCES AB201 DEVELOPMENT PROGRAM FOR TREATMENT OF COVID-19 ASSOCIATED COAGULOPATHY

* ARCA BIOPHARMA - ANTICIPATES FILING AN IND IN Q3 2020 & INITIATING LATE-STAGE CLINICAL TESTING IN H2 OF THIS YEAR Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up